UK markets closed

Arcutis Biotherapeutics, Inc. (ARQT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.20+0.08 (+0.88%)
At close: 04:00PM EDT
9.20 0.00 (0.00%)
After hours: 07:40PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6677
Avg. Estimate-0.58-0.52-2.04-1.27
Low estimate-0.87-0.77-3.14-1.59
High estimate-0.5-0.4-1.6-1.04
Year ago EPS-1.16-0.73-3.78-2.04
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts6677
Avg. Estimate27.12M34.93M146.13M239.3M
Low estimate21M29.7M109.4M207.9M
High estimate31M38.2M168M263.7M
Year ago sales5.19M32.83M59.61M146.13M
Sales growth (year/est)422.50%6.40%145.20%63.80%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-1.25-0.86-0.77-0.73
Actual EPS-1.16-0.73-0.72-0.32
Difference0.090.130.050.41
Surprise %7.20%15.10%6.50%56.20%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.58-0.52-2.04-1.27
7 days ago-0.67-0.55-2.4-1.31
30 days ago-0.69-0.6-2.51-1.46
60 days ago-0.69-0.6-2.51-1.46
90 days ago-0.75-0.68-2.59-1.64
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days4355
Up last 30 days4455
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesARQTIndustrySector(s)S&P 500
Current qtr.50.00%N/AN/AN/A
Next qtr.28.80%N/AN/AN/A
Current year46.00%N/AN/AN/A
Next year37.70%N/AN/AN/A
Next 5 years (per annum)9.80%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A